Collectively, these findings demonstrate that c-Met CAR macrophages effectively inhibit Angiogenesis within the pancreatic cancer tumor microenvironment, promote normalization of tumor vasculature, and thereby effectively delay tumor progression. The gene discussed is MET; the disease is familial pancreatic carcinoma.